Award
Delivery Order #SPE2D326F6830
Delivery Order for Pharmaceutical Syringe Under Long-Term Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$38.52
Ceiling
$38.52
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2D326F6830
NAICS
325411
This award represents a delivery order contract awarded to Sagent Pharmaceuticals, Inc., a prominent manufacturer and distributor specializing in generic pharmaceuticals. The order procures a specific pharmaceutical product—glycopyrrolate 2% jelly in an 11ml syringe—to support ongoing medical needs. This transaction is part of a larger, previously awarded long-term indefinite delivery vehicle (IDV) contract focused on the reliable manufacture and supply of critical medications for military and public health applications. The significance of this contract lies in its role in ensuring timely availability of essential pharmaceutical products, thereby reinforcing healthcare readiness and operational effectiveness. The scope includes the precise fulfillment and delivery of the specified pharmaceutical syringe within a short performance window. This award was made under the existing competitively awarded contract, demonstrating adherence to rigorous procurement standards. The contract's timeline is brief, covering a multi-day period for delivery, indicative of efficient supply chain operations. The delivery order supplements the agency's sustained commitment to pharmaceutical resilience facilitated by Sagent Pharmaceuticals' proven performance.
Description
4571002349!GLYDO 2% JELLY SYRINGE 11ML